No Data
Tianjin Tianyao Pharmaceuticals (600488.SH): Signed the "Equity Custody Agreement".
On January 7, Gronghui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced that after approval by the company's ninth Board of Directors at the thirteenth meeting, to avoid potential competition issues with Innovent Biologics in the future, and since Innovent Biologics does not currently meet the conditions for injection into the listed company based on its Financial Indicators and Operation status, the company signed an "Equity Custody Agreement" with its affiliated party Tianyan Biotechnology, entrusting the management of the 55.5222% equity of Innovent Biologics owned by Tianyan Biotechnology, with the custody period from January 7, 2025, to January 6, 2028.
Tianjin Tianyao Pharmaceuticals Gets Listing Approval for Dexamethasone Sodium Phosphate API in Brazil
Tianjin Tianyao Pharmaceuticals (600488.SH): Dexamethasone phosphate Active Pharmaceutical Ingredient has been approved for sale in Brazil.
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that the company received notification from the Brazilian Health Regulatory Agency (referred to as "ANVISA...")
Tianjin Tianyao Pharmaceuticals Co., Ltd.'s (SHSE:600488) Prospects Need A Boost To Lift Shares
Tianjin Tianyao Pharmaceuticals (600488.SH): A subsidiary's products are expected to be selected in the national pharmaceutical centralized procurement.
On December 16, Gelonghui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its controlling subsidiary, Tianjin Tianyao Heping Pharmaceutical Co., Ltd. (referred to as "Tianyan Heping"), participated in the tenth round of nationwide centralized pharmaceutical procurement organized by the Joint Procurement Office (referred to as "Joint Procurement Office"), with four products: aminophylline injection, fluorouracil injection, methoxamine injection, and methoxamine hydrochloride injection expected to be selected for this centralized procurement.
Tianjin Tianyao Pharmaceuticals Gets China Nod for Autoimmune Anti-Inflammatory Injection
Earnings Not Telling The Story For Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE:600488)
